Losing Allergan deals blow to Valeant reputation
November 17, 2014 at 13:25 PM EST
WINNIPEG/NEW YORK Nov 17 (Reuters) - The failure of Valeant Pharmaceuticals International Inc to buy Allergan Inc leaves it with nothing to show for a seven-month, bruising pursuit.